Randomized Clinical Trial
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1765-1774
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1765
Table 2 Baseline characteristics of study participants, n (%)/mean ± SD

Peptide-based formula (n = 9)
Standard formula
(n = 10)
P value
Demographic
Age (yr)60.1 ± 21.649.1 ± 26.00.333
Gender (Male)7 (77.8)9 (90.0)0.466
Weight (kg)66.2 ± 14.362.6 ± 10.40.533
BMI (kg/m2)24.2 ± 3.122.4 ± 3.80.275
GCS score10.7 ± 3.010.0 ± 3.10.864
SOFA score4.0 ± 2.04.2 ± 2.00.769
1Nutrition status assessment
Risk of malnutrition4 (44.4)3 (30.0)0.752
Mild malnutrition4 (44.4)5 (50.0)
Moderate malnutrition0 (0.0)1 (10.0)
Severe malnutrition1 (11.1)1 (10.0)
Biochemistry
Hemoglobin (g/dL)9.8 ± 2.410.1 ± 1.80.793
White blood cells count (× 103/μL)14.8 ± 4.215.0 ± 7.50.955
Platelets count (× 103/μL)218.8 ± 112.7175.5 ± 85.50.253
Neutrophils84.3 ± 8.583.5 ± 5.80.826
Monocytes6.3 ± 3.57.2 ± 3.80.513
Total lymphocytes count (cell/μL)1267.1± 1164.81006.0 ± 1005.60.288
Blood urea nitrogen (mg/dL)22.3 ± 8.721.3 ± 20.60.327
Creatinine (mg/dL)1.1 ± 0.41.0 ± 0.90.102
Urine urea nitrogen12.0 ± 6.415.4 ± 22.20.441
GFR (mL/min/1.73 m²)74.7± 31.6103.5 ± 35.80.082
Fasting plasma glucose (mg/dL)128.0 ± 26.7128.1 ± 49.10.374
Alkaline phosphatase (U/L)92.1 ± 41.296.3 ± 64.60.859
Aspartate transaminase (U/L)84.5 ± 52.0104.3 ± 66.50.501
Alanine transaminase (U/L)32.5 ± 26.086.8 ± 99.80.154
Nutritional status
Albumin (g/dL)2.6 ± 0.62.5 ± 0.50.821
Prealbumin (mg/dL)10.2 ± 5.314.1 ± 8.20.236
Retinol binding protein (mg/dL)2.1 ± 1.72.0 ± 1.31.000